This content is restricted.
Brief
On December 16, 2024, the Therapeutic Goods Administration (TGA) issued an update regarding Product Information safety updates - December 2024. The TGA reported safety-related changes to the product information for several medicines, including Eylea, Botox, and Ilaris, among others, which may affect prescribers' and patients' treatment plans and require special precautions or monitoring.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested